 Scavenger Receptors, Class E
"Scavenger Receptors, Class E" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of oxidized LDL receptors that contain LECTIN-like extracellular domains.
| Descriptor ID |
D051127
|
| MeSH Number(s) |
D12.776.543.750.705.940.734 D12.776.543.750.710.450.625.500 D12.776.543.750.710.450.750.734
|
| Concept/Terms |
Scavenger Receptors, Class E, Type I- Scavenger Receptors, Class E, Type I
- SR-EI Proteins
- SR EI Proteins
- Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1
- Lectin Like Oxidized Low Density Lipoprotein Receptor 1
|
Below are MeSH descriptors whose meaning is more general than "Scavenger Receptors, Class E".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Scavenger [D12.776.543.750.705.940]
- Scavenger Receptors, Class E [D12.776.543.750.705.940.734]
- Receptors, Lipoprotein [D12.776.543.750.710]
- Receptors, LDL [D12.776.543.750.710.450]
- Receptors, Oxidized LDL [D12.776.543.750.710.450.625]
- Scavenger Receptors, Class E [D12.776.543.750.710.450.625.500]
- Receptors, Scavenger [D12.776.543.750.710.450.750]
- Scavenger Receptors, Class E [D12.776.543.750.710.450.750.734]
Below are MeSH descriptors whose meaning is more specific than "Scavenger Receptors, Class E".
This graph shows the total number of publications written about "Scavenger Receptors, Class E" by people in UAMS Profiles by year, and whether "Scavenger Receptors, Class E" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 | | 2022 | 2 | 1 | 3 | | 2020 | 1 | 1 | 2 | | 2019 | 2 | 0 | 2 | | 2018 | 2 | 0 | 2 | | 2017 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 | | 2015 | 5 | 3 | 8 | | 2014 | 6 | 0 | 6 | | 2013 | 6 | 1 | 7 | | 2012 | 3 | 3 | 6 | | 2011 | 15 | 2 | 17 | | 2010 | 5 | 0 | 5 | | 2009 | 4 | 2 | 6 | | 2008 | 3 | 0 | 3 | | 2007 | 9 | 1 | 10 | | 2006 | 3 | 0 | 3 | | 2005 | 4 | 3 | 7 | | 2004 | 0 | 3 | 3 | | 2003 | 0 | 5 | 5 | | 2002 | 0 | 2 | 2 | | 2001 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Scavenger Receptors, Class E" by people in Profiles over the past ten years.
-
Khan MA, Mohammad I, Banerjee S, Tomar A, Varughese KI, Mehta JL, Chandele A, Arockiasamy A. Oxidized LDL receptors: a recent update. Curr Opin Lipidol. 2023 08 01; 34(4):147-155.
-
Korkmaz FT, Shenoy AT, Symer EM, Baird LA, Odom CV, Arafa EI, Dimbo EL, Na E, Molina-Arocho W, Brudner M, Standiford TJ, Mehta JL, Sawamura T, Jones MR, Mizgerd JP, Traber KE, Quinton LJ. Lectin-like oxidized low-density lipoprotein receptor 1 attenuates pneumonia-induced lung injury. JCI Insight. 2022 12 08; 7(23).
-
Tomar A, Sahoo S, Aathi M, Kuila S, Khan MA, Ravi GRR, Jeyaraman J, Mehta JL, Varughese KI, Arockiasamy A. Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis. Biochem Biophys Res Commun. 2022 10 01; 623:59-65.
-
Kore RA, Bagchi AK, Varughese KI, Mehta JL. The structural basis of effective LOX-1 inhibition. Future Med Chem. 2022 05; 14(10):731-743.
-
Bagchi AK, Surendran A, Malik A, Jassal DS, Ravandi A, Singal PK. IL-10 attenuates OxPCs-mediated lipid metabolic responses in ischemia reperfusion injury. Sci Rep. 2020 07 21; 10(1):12120.
-
Ding Z, Pothineni NVK, Goel A, L?scher TF, Mehta JL. PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1. Cardiovasc Res. 2020 04 01; 116(5):908-915.
-
Kore RA, Henson JC, Hamzah RN, Griffin RJ, Tackett AJ, Ding Z, Mehta JL. Molecular events in MSC exosome mediated cytoprotection in cardiomyocytes. Sci Rep. 2019 12 17; 9(1):19276.
-
Kattoor AJ, Kanuri SH, Mehta JL. Role of Ox-LDL and LOX-1 in Atherogenesis. Curr Med Chem. 2019; 26(9):1693-1700.
-
Ding Z, Liu S, Wang X, Theus S, Deng X, Fan Y, Zhou S, Mehta JL. PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages. Cardiovasc Res. 2018 07 01; 114(8):1145-1153.
-
Dai Y, Wu X, Dai D, Li J, Mehta JL. MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1. Redox Biol. 2018 06; 16:255-262.
-
Pothineni NVK, Karathanasis SK, Ding Z, Arulandu A, Varughese KI, Mehta JL. LOX-1 in Atherosclerosis and Myocardial?Ischemia: Biology, Genetics, and Modulation. J Am Coll Cardiol. 2017 Jun 06; 69(22):2759-2768.
-
Dai Y, Cao Y, Zhang Z, Vallurupalli S, Mehta JL. Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation. Cardiovasc Drugs Ther. 2017 Feb; 31(1):19-27.
-
Dai Y, Zhang Z, Cao Y, Mehta JL, Li J. MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1. Sci Rep. 2016 Mar 02; 6:22607.
-
Kirby TJ, Walton RG, Finlin B, Zhu B, Unal R, Rasouli N, Peterson CA, Kern PA. Integrative mRNA-microRNA analyses reveal novel interactions related to insulin sensitivity in human adipose tissue. Physiol Genomics. 2016 Feb; 48(2):145-53.
-
Thakkar S, Wang X, Khaidakov M, Dai Y, Gokulan K, Mehta JL, Varughese KI. Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein. Sci Rep. 2015 Nov 18; 5:16740.
-
Wang X, Ding Z, Lin J, Guo Z, Mehta JL. LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains. Biochem Biophys Res Commun. 2015 Nov 06; 467(1):135-9.
-
Ding Z, Liu S, Wang X, Deng X, Fan Y, Shahanawaz J, Shmookler Reis RJ, Varughese KI, Sawamura T, Mehta JL. Cross-talk between LOX-1 and PCSK9 in vascular tissues. Cardiovasc Res. 2015 Sep 01; 107(4):556-67.
-
Yao-Borengasser A, Monzavi-Karbassi B, Hedges RA, Rogers LJ, Kadlubar SA, Kieber-Emmons T. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells. Oncol Rep. 2015 Jun; 33(6):2689-94.
-
Ding Z, Liu S, Wang X, Khaidakov M, Fan Y, Deng X, Xiang D, Mehta JL. Lectin-like oxidized low-density lipoprotein receptor-1 regulates autophagy and Toll-like receptor 4 in the brain of hypertensive mice. J Hypertens. 2015 Mar; 33(3):525-33; discussion 533.
-
Ding Z, Liu S, Deng X, Fan Y, Wang X, Mehta JL. Hemodynamic shear stress modulates endothelial cell autophagy: Role of LOX-1. Int J Cardiol. 2015 Apr 01; 184:86-95.
-
Ding Z, Liu S, Wang X, Deng X, Fan Y, Sun C, Wang Y, Mehta JL. Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta. Antioxid Redox Signal. 2015 Mar 20; 22(9):760-71.
-
Wang X, Khaidakov M, Guo Z, Ding Z, He Q, Mehta JL. LOX-1 deletion limits cardiac angiogenesis in mice given angiotensin II. Cardiovasc Drugs Ther. 2014 Oct; 28(5):441-6.
-
Ding Z, Liu S, Wang X, Theus S, Fan Y, Deng X, Mehta JL. LOX-1 - dependent mitochondrial DNA damage and NLRP3 activation during systemic inflammation in mice. Biochem Biophys Res Commun. 2014 Sep 05; 451(4):637-43.
-
Ding Z, Liu S, Wang X, Khaidakov M, Dai Y, Deng X, Fan Y, Xiang D, Mehta JL. Lectin-like ox-LDL receptor-1 (LOX-1)-Toll-like receptor 4 (TLR4) interaction and autophagy in CATH.a differentiated cells exposed to angiotensin II. Mol Neurobiol. 2015 Apr; 51(2):623-32.
-
Ding Z, Liu S, Wang X, Dai Y, Khaidakov M, Deng X, Fan Y, Xiang D, Mehta JL. LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis. Cardiovasc Res. 2014 Sep 01; 103(4):619-28.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|